Skip to content
Methodology
All entries for: NS Pharma Inc.
September 5, 2025
NS Pharma Inc.
Orphan Drug Designation
FDA orphan drug designation: treatment of Duchenne muscular dystrophy
Disease Area:
Rare Diseases
Source
Scroll to Top
